|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 10, 2022
|
Q2 FY2022
As of Jun 18, 2022
|
Q1 FY2022
As of Mar 26, 2022
|
Q4 FY2021
As of Jan 1, 2022
|
Q3 FY2021
As of Sep 11, 2021
|
Q2 FY2021
As of Jun 19, 2021
|
Q1 FY2021
As of Mar 27, 2021
|
Q4 FY2020
As of Jan 2, 2021
|
Q3 FY2020
As of Sep 5, 2020
|
Q2 FY2020
As of Jun 13, 2020
|
Q1 FY2020
As of Mar 21, 2020
|
Q4 FY2019
As of Dec 28, 2019
|
Q3 FY2019
As of Sep 7, 2019
|
Q2 FY2019
As of Jun 15, 2019
|
Q1 FY2019
As of Mar 23, 2019
|
Q4 FY2018
As of Dec 29, 2018
|
Q3 FY2018
As of Sep 8, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable - net | ||||||||||||||||||||
| Inventory - net | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment - net | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Equipment at customers - net | ||||||||||||||||||||
| Software and intangible assets - net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Investments at fair value | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Current portion of lease liabilities | ||||||||||||||||||||
| Contract liabilities - net | ||||||||||||||||||||
| Accrued salaries, wages, and benefits | ||||||||||||||||||||
| Taxes payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Revolving credit facility | ||||||||||||||||||||
| Current portion of long term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Lease liabilities, net of current portion | ||||||||||||||||||||
| Other long term liabilities | ||||||||||||||||||||
| Long-term debt - net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY: | ||||||||||||||||||||
| Common stock - 36,000,000 shares authorized at $0.01 par value, 23,687,649 and 23,593,163 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||||
| Common stock, par value (in dollars per share) | ||||||||||||||||||||
| Common stock, shares issued (in shares) |
Loading...
